11. Loss Per Share

Basic and diluted loss per share were calculated as follows (shares in thousands):

		Quarter ended						Two quarters ended
		June 29, 2024			July 1, 2023			June 29, 2024			July 1, 2023
Numerator
Earnings (loss) from continuing operations	$	(3,781	)	$	(11,651	)	$	56		$	(14,478	)
Less: dividends and accretion on preferred stock		169			(422	)		(264	)		(1,126	)
Loss from continuing operations attributable to
common shareholders		(3,612	)		(12,073	)		(208	)		(15,604	)
Loss from discontinued operations		(897	)		(7,187	)		(2,314	)		(2,983	)
Loss attributable to common shareholders	$	(4,509	)	$	(19,260	)	$	(2,522	)	$	(18,587	)

Denominator
Basic weighted-average number of shares outstanding		116,640			115,471			116,336			112,743
Dilutive effect of the following:
Stock options, restricted stock units and performance share units⁽¹⁾		-			-			-			-
Series B-1 Preferred Stock⁽²⁾		-			-			-			-
Diluted weighted-average number of shares outstanding		116,640			115,471			116,336			112,743

Basic and Diluted Loss Per Share
Loss from continuing operations attributable to common shareholders	$	(0.03	)	$	(0.10	)	$	(0.00	)	$	(0.14	)
Loss from discontinued operations		(0.01	)		(0.06	)		(0.02	)		(0.03	)
Loss attributable to common shareholders⁽³⁾	$	(0.04	)	$	(0.17	)	$	(0.02	)	$	(0.16	)

(1) For the quarter and two quarters ended June 29, 2024, 711,000 (July 1, 2023 - 1,024,173) and 1,058,529 (July 1, 2023 - 1,974,484) potential common shares, respectively, were excluded from the calculation of diluted loss per share due to their effect of reducing the loss per share from continuing operations. Dilutive potential common shares consist of stock options, RSUs, and certain contingently issuable PSUs. For the quarter and two quarters ended June 29, 2024, stock options and RSUs to purchase or receive 2,801,823 (July 1, 2023 - 2,204,546) and 2,751,020 (July 1, 2023 - 2,192,755) potential common shares, respectively, were anti-dilutive because the assumed proceeds exceeded the average market price of the Common Shares for the respective periods.

(2) For the quarters and two quarters ended June 29, 2024 and July 1, 2023, it was more dilutive to assume the Series B-1 Preferred Stock was not converted into Common Shares and, therefore, the numerator of the diluted loss per share calculation was not adjusted to add back the dividends and accretion on the Series B-1 Preferred Stock and the denominator was not adjusted to include the 6,089,333 Common Shares issuable on an if-converted basis as at June 29, 2024 and July 1, 2023.

(3) The sum of the individual per share amounts may not add due to rounding.